Central nervous system cancers, version 1.2015: Featured updates to the NCCN guidelines

Louis Burt Nabors; Jana Portnow; Mario Ammirati; Joachim Baehring; Henry Brem; Paul Brown; Nicholas Butowski; Marc C. Chamberlain; Robert A. Fenstermaker; Allan Friedman; Mark R. Gilbert; Jona Hattangadi-Gluth; Matthias Holdhoff; Larry Junck; Thomas Kaley; Ronald Lawson; Jay S. Loeffler; Mary P. Lovely; Paul L. Moots; Maciej M. Mrugala; Herbert B. Newton; Ian Parney; Jeffrey J. Raizer; Lawrence Recht; Nicole Shonka; Dennis C. Shrieve; Allen K. Sills; Lode J. Swinnen; David Tran; Nam Tran; Frank D. Vrionis; Stephanie Weiss; Patrick Yung Wen; Nicole McMillian; Anita M. Engh

doi:10.6004/jnccn.2015.0148

Central nervous system cancers, version 1.2015: Featured updates to the NCCN guidelines

Louis Burt Nabors
, Jana Portnow
, Mario Ammirati
, Joachim Baehring
, Henry Brem
, Paul Brown
, Nicholas Butowski
, Marc C. Chamberlain
, Robert A. Fenstermaker
, Allan Friedman
, Mark R. Gilbert
, Jona Hattangadi-Gluth
, Matthias Holdhoff
, Larry Junck
, Thomas Kaley
, Ronald Lawson
, Jay S. Loeffler
, Mary P. Lovely
, Paul L. Moots
, Maciej M. Mrugala

Herbert B. Newton, Ian Parney, Jeffrey J. Raizer, Lawrence Recht, Nicole Shonka, Dennis C. Shrieve, Allen K. Sills, Lode J. Swinnen, David Tran, Nam Tran, Frank D. Vrionis, Stephanie Weiss, Patrick Yung Wen, Nicole McMillian, Anita M. Engh

Research output: Contribution to journal › Review article › peer-review

101 Scopus citations

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Central Nervous System (CNS) Cancers provide interdisciplinary recommendations for managing adult CNS cancers. Primary and metastatic brain tumors are a heterogeneous group of neoplasms with varied outcomes and management strategies. These NCCN Guidelines Insights summarize the NCCN CNS Cancers Panel's discussion and highlight notable changes in the 2015 update. This article outlines the data and provides insight into panel decisions regarding adjuvant radiation and chemotherapy treatment options for high-risk newly diagnosed low-grade gliomas and glioblastomas. Additionally, it describes the panel's assessment of new data and the ongoing debate regarding the use of alternating electric field therapy for high-grade gliomas.

Original language	English
Pages (from-to)	1191-1202
Number of pages	12
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	13
Issue number	10
DOIs	https://doi.org/10.6004/jnccn.2015.0148
State	Published - Oct 1 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.6004/jnccn.2015.0148

Cite this

Nabors, L. B., Portnow, J., Ammirati, M., Baehring, J., Brem, H., Brown, P., Butowski, N., Chamberlain, M. C., Fenstermaker, R. A., Friedman, A., Gilbert, M. R., Hattangadi-Gluth, J., Holdhoff, M., Junck, L., Kaley, T., Lawson, R., Loeffler, J. S., Lovely, M. P., Moots, P. L., ... Engh, A. M. (2015). Central nervous system cancers, version 1.2015: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 13(10), 1191-1202. https://doi.org/10.6004/jnccn.2015.0148

@article{d4fa578104454d8a929fedc57b5ce470,

title = "Central nervous system cancers, version 1.2015: Featured updates to the NCCN guidelines",

abstract = "The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Central Nervous System (CNS) Cancers provide interdisciplinary recommendations for managing adult CNS cancers. Primary and metastatic brain tumors are a heterogeneous group of neoplasms with varied outcomes and management strategies. These NCCN Guidelines Insights summarize the NCCN CNS Cancers Panel's discussion and highlight notable changes in the 2015 update. This article outlines the data and provides insight into panel decisions regarding adjuvant radiation and chemotherapy treatment options for high-risk newly diagnosed low-grade gliomas and glioblastomas. Additionally, it describes the panel's assessment of new data and the ongoing debate regarding the use of alternating electric field therapy for high-grade gliomas.",

author = "Nabors, \{Louis Burt\} and Jana Portnow and Mario Ammirati and Joachim Baehring and Henry Brem and Paul Brown and Nicholas Butowski and Chamberlain, \{Marc C.\} and Fenstermaker, \{Robert A.\} and Allan Friedman and Gilbert, \{Mark R.\} and Jona Hattangadi-Gluth and Matthias Holdhoff and Larry Junck and Thomas Kaley and Ronald Lawson and Loeffler, \{Jay S.\} and Lovely, \{Mary P.\} and Moots, \{Paul L.\} and Mrugala, \{Maciej M.\} and Newton, \{Herbert B.\} and Ian Parney and Raizer, \{Jeffrey J.\} and Lawrence Recht and Nicole Shonka and Shrieve, \{Dennis C.\} and Sills, \{Allen K.\} and Swinnen, \{Lode J.\} and David Tran and Nam Tran and Vrionis, \{Frank D.\} and Stephanie Weiss and Wen, \{Patrick Yung\} and Nicole McMillian and Engh, \{Anita M.\}",

year = "2015",

month = oct,

day = "1",

doi = "10.6004/jnccn.2015.0148",

language = "English",

volume = "13",

pages = "1191--1202",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "10",

}

Nabors, LB, Portnow, J, Ammirati, M, Baehring, J, Brem, H, Brown, P, Butowski, N, Chamberlain, MC, Fenstermaker, RA, Friedman, A, Gilbert, MR, Hattangadi-Gluth, J, Holdhoff, M, Junck, L, Kaley, T, Lawson, R, Loeffler, JS, Lovely, MP, Moots, PL, Mrugala, MM, Newton, HB, Parney, I, Raizer, JJ, Recht, L, Shonka, N, Shrieve, DC, Sills, AK, Swinnen, LJ, Tran, D, Tran, N, Vrionis, FD, Weiss, S, Wen, PY, McMillian, N & Engh, AM 2015, 'Central nervous system cancers, version 1.2015: Featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 13, no. 10, pp. 1191-1202. https://doi.org/10.6004/jnccn.2015.0148

TY - JOUR

T1 - Central nervous system cancers, version 1.2015

T2 - Featured updates to the NCCN guidelines

AU - Nabors, Louis Burt

AU - Portnow, Jana

AU - Ammirati, Mario

AU - Baehring, Joachim

AU - Brem, Henry

AU - Brown, Paul

AU - Butowski, Nicholas

AU - Chamberlain, Marc C.

AU - Fenstermaker, Robert A.

AU - Friedman, Allan

AU - Gilbert, Mark R.

AU - Hattangadi-Gluth, Jona

AU - Holdhoff, Matthias

AU - Junck, Larry

AU - Kaley, Thomas

AU - Lawson, Ronald

AU - Loeffler, Jay S.

AU - Lovely, Mary P.

AU - Moots, Paul L.

AU - Mrugala, Maciej M.

AU - Newton, Herbert B.

AU - Parney, Ian

AU - Raizer, Jeffrey J.

AU - Recht, Lawrence

AU - Shonka, Nicole

AU - Shrieve, Dennis C.

AU - Sills, Allen K.

AU - Swinnen, Lode J.

AU - Tran, David

AU - Tran, Nam

AU - Vrionis, Frank D.

AU - Weiss, Stephanie

AU - Wen, Patrick Yung

AU - McMillian, Nicole

AU - Engh, Anita M.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Central Nervous System (CNS) Cancers provide interdisciplinary recommendations for managing adult CNS cancers. Primary and metastatic brain tumors are a heterogeneous group of neoplasms with varied outcomes and management strategies. These NCCN Guidelines Insights summarize the NCCN CNS Cancers Panel's discussion and highlight notable changes in the 2015 update. This article outlines the data and provides insight into panel decisions regarding adjuvant radiation and chemotherapy treatment options for high-risk newly diagnosed low-grade gliomas and glioblastomas. Additionally, it describes the panel's assessment of new data and the ongoing debate regarding the use of alternating electric field therapy for high-grade gliomas.

AB - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Central Nervous System (CNS) Cancers provide interdisciplinary recommendations for managing adult CNS cancers. Primary and metastatic brain tumors are a heterogeneous group of neoplasms with varied outcomes and management strategies. These NCCN Guidelines Insights summarize the NCCN CNS Cancers Panel's discussion and highlight notable changes in the 2015 update. This article outlines the data and provides insight into panel decisions regarding adjuvant radiation and chemotherapy treatment options for high-risk newly diagnosed low-grade gliomas and glioblastomas. Additionally, it describes the panel's assessment of new data and the ongoing debate regarding the use of alternating electric field therapy for high-grade gliomas.

UR - https://www.scopus.com/pages/publications/84944744220

U2 - 10.6004/jnccn.2015.0148

DO - 10.6004/jnccn.2015.0148

M3 - Review article

C2 - 26483059

SN - 1540-1405

VL - 13

SP - 1191

EP - 1202

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 10

ER -

Central nervous system cancers, version 1.2015: Featured updates to the NCCN guidelines

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this